United States - English - NLM (National Library of Medicine)

teva respiratory, llc - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 80 ug - qnasl® nasal aerosol is indicated for the treatment of the nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. qnasl nasal aerosol is contraindicated in patients with a history of hypersensitivity to beclomethasone dipropionate and/or any other qnasl nasal aerosol ingredients [see warnings and precautions (5.3)] . teratogenic effects : pregnancy category c there are no adequate and well-controlled clinical trials in pregnant women treated with qnasl nasal aerosol. beclomethasone dipropionate was teratogenic and embryocidal in the mouse and rabbit although these effects were not observed in rats. qnasl nasal aerosol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. experience with oral corticosteroids since their introduction in pharmacologic, as opposed to physiologic, doses suggests that rodents are more prone to teratogenic effects from corticosteroids than humans. beclomethasone dipropionate ad

Namibia - English - Namibia Medicines Regulatory Council

sandoz (sa) (pty) ltd - beclomethasone dipropionate - nasal spray - beclomethasone dipropionate 50 ?g

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid berhad - beclomethasone dipropionate; clotrimazole -

Namibia - English - Namibia Medicines Regulatory Council

sandoz s a (pty) ltd - beclomethasone dipropionate - nasal spray - each metered spray contains 50?g beclomethasone dipropionate

Canada - English - Health Canada

kenral inc. - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - anti-inflammatory agents

Canada - English - Health Canada

pharmaco canada inc. - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - anti-inflammatory agents

United States - English - NLM (National Library of Medicine)

teva respiratory, llc - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 40 ug - qvar® is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. important limitations of use: - qvar is not indicated for the relief of acute bronchospasm. 4.1 status asthmaticus qvar is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. 4.2 hypersensitivity qvar is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar [see warnings and precautions (5.6)]. risk summary there are no adequate and well-controlled studies with qvar or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases in congenital malformations or other

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 80 ug - qvar® is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. important limitations of use: 4.1 status asthmaticus qvar is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. 4.2 hypersensitivity qvar is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar [see warnings and precautions (5.6)]. risk summary there are no adequate and well-controlled studies with qvar or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases in congenital malformations or other adverse perinatal outcomes. thus, available human data do not

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone 17-monopropionate - unii:5bga9fd55h) - beclomethasone dipropionate 40 ug - qvar is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. qvar is also indicated for asthma patients who require systemic corticosteroid administration, where adding qvar may reduce or eliminate the need for the systemic corticosteroids. beclomethasone dipropionate is not indicated for the relief of acute bronchospasm. qvar is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. hypersensitivity to any of the ingredients of this preparation contraindicates its use.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 80 ug - qvar® is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. important limitations of use: - qvar is not indicated for the relief of acute bronchospasm. 4.1 status asthmaticus qvar is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. 4.2 hypersensitivity qvar is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar [see warnings and precautions (5.6)]. risk summary there are no adequate and well-controlled studies with qvar or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases in congenital malformations or other